This has also been reported for other EP4 agonists [17] and might be explained by the fact that the EP4 receptor is also involved in regulating pain and inflammation and that EP4 receptor antagonists are currently in development as pharmaceuticals to control pain and inflammation associated with osteoarthritis in veterinary patients [30]. The gene discussed is PTGER4; the disease is osteoarthritis.